HFM
MRNA icon

Harvest Fund Management’s Moderna MRNA Stock Holding History

Harvest Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,707
Closed -$1.18M – 802
2024
Q3 		$1.18M Buy
17,707
+5,544
+46% +$509K 0.07% 171
2024
Q2 		$1.44M Sell
12,163
-134
-1% -$17K 0.1% 116
2024
Q1 		$1.31M Buy
12,297
+8,910
+263% +$898K 0.12% 119
2023
Q4 		$333K Buy
3,387
+356
+12% +$29.9K 0.05% 160
2023
Q3 		$313K Buy
3,031
+1,123
+59% +$125K 0.05% 153
2023
Q2 		$232K Buy
1,908
+861
+82% +$115K 0.05% 176
2023
Q1 		$161K Sell
1,047
-1,052
-50% -$174K 0.04% 247
2022
Q4 		$373K Buy
2,099
+1,211
+136% +$198K 0.1% 127
2022
Q3 		$105K Sell
888
-644
-42% -$97.7K 0.03% 292
2022
Q2 		$219K Sell
1,532
-286
-16% -$40.9K 0.06% 158
2022
Q1 		$313K Sell
1,818
-870
-32% -$146K 0.07% 139
2021
Q4 		$673K Sell
2,688
-672
-20% -$196K 0.11% 75
2021
Q3 		$1.29M Buy
3,360
+596
+22% +$220K 0.29% 35
2021
Q2 		$649K Buy
2,764
+212
+8% +$37.9K 0.07% 67
2021
Q1 		$334K Sell
2,552
-324
-11% -$47K 0.03% 88
2020
Q4 		$300K Buy
2,876
+90
+3% +$9.11K 0.03% 108
2020
Q3 		$200K Buy
2,786
+901
+48% +$62.8K 0.02% 158
2020
Q2 		$116K Sell
1,885
-1,494
-44% -$81.8K 0.01% 213
2020
Q1 		$95K Buy
+3,379
New +$77.7K 0.01% 208

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Harvest Fund Management's MRNA Position: Q4 2024 in Review

Harvest Fund Management sold out of Moderna (MRNA) in Q4 2024, closing a stake of 17,707 shares — an estimated $1.18M sold.

Harvest Fund Management first reported a position in MRNA in Q1 2020 and held it in 19 quarters. The position peaked at $1.44M in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Harvest Fund Management reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Harvest Fund Management sold 17,707 Moderna shares in Q4 2024, an estimated $1.18M.
  • Harvest Fund Management first reported a position in Moderna in Q1 2020 and held it in 19 quarters.
  • Harvest Fund Management's Moderna position peaked at $1.44M in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Harvest Fund Management's 13F filing for Q4 2024, filed 11 Feb 2025.